number need treat tz whatamido epidemiolog pharmacolog number need treat nnt epidemiolog measur assess effect healthcar intervent typic treatment medic nnt number patient treat order prevent addit bad outcom reduc expect number case defin endpoint defin invers absolut risk reduct describ deriv gener nnt comput respect treatment typic drug placebo year treatment drug treatment defin endpoint appear colon cancer fiveyear period probabl pa pb endpoint treatment nnt comput pb pa relev nnt measur pharmacoeconom clinic endpoint devast death heart attack drug high nnt indic situat endpoint minor health insur declin reimburs drug high nnt exampl statin primari prevent exampl ascotlla manufacturersponsor studi address benefit atorvastatin cholesterollow drug patient hypertens high blood pressur previou cardiovascular diseas primari prevent trial year period rel risk primari event heart attack reduc absolut risk reduct arr smaller studi group high rate cardiovascular event studi period control group compar treatment group atorvastatin year lead arr minu number need treat prevent cardiovascular event year work exampl abbrevi variabl equat subject control group subject experiment group event control group event experiment group cer control event rate event subject control group eer experiment event rate event subject experiment group arr absolut risk reduct increas cer eer rrr rel risk reductionor increas cer eer cer nnt number need treat number need harm arr rr odd ratio rel risknot ident articl detail cer eer rel risk odd ratio exampl rel risk reduct vice versa number need harm convers sideeffect refer laupaci sackett dl robert rs assess clinic measur consequ treatment engl med pmid sever ps dahlf poulter nr al prevent coronari stroke event atorvastatin hypertens patient averag lowerthanaverag cholesterol concentr angloscandinavian cardiac outcom triallipid lower arm ascotlla multicentr randomis control trial lancet doi pmid bandoli statin effect ascot updat retriev cholesterol drug good busi week retriev larg clinic studi patient sugar pill placebo heart attack compar patient lipitor number sentenc peopl trial last year three peopl placebo peopl lipitor heart attack fewer heart attack peopl spare person heart attack peopl lipitor three year measur benefit term littleknown statist number need treat nnt person benefit extern link ebem calcul nnt onlin calcul nnt graphpad softwar